Close

VBI Vaccines (VBIV) Granted FDA Approval of Investigational New Drug Application for Sci-B-Vac(R) Phase 3 Clinical Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. TXN
3. ENPH
4. SPOT
5. V
6. MAT
7. MSCI
8. STX
9. TMO
10. DHR


Go back to VBI Vaccines (VBIV) Granted FDA Approval of Investigational New Drug Application for Sci-B-Vac(R) Phase 3 Clinical Program
(NASDAQ: VBIV) Delayed: 0.61 --0 (-0%)
Previous Close $0.61    52 Week High $4.35 
Open $0.61    52 Week Low $1.76 
Day High $0.61    P/E N/A 
Day Low $0.61    EPS $0.00 
Volume 10